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Nerve crush injuries are commonly used models for axonotmesis to examine peripheral nerve regeneration. As evening primrose
oil (EPO) is rich in omega-6 essential fatty acid component and gamma-linolenic acid, studies have shown the potential role of EPO
in myelination. Seventy-two healthy adult Sprague-Dawley rats were classified into three groups: normal group, control group, and
experimental group. The result indicates that there was significant difference in toe-spreading reflex between the normal and the
control groups (1.9±0.031, 𝑝 < 0.05) and the normal and the EPO groups (0.4±0.031, 𝑝 < 0.05) and significant difference between
EPO and the control groups (1.5 ± 0.031, 𝑝 < 0.05). Regeneration of axons and myelin in nerve fibre in the EPO-treated group
developed better and faster than in the control group. In the control group, the shape of the axon was irregular with a thinner
myelin sheath. In the experimental group, the shape of the axons, the thickness of the myelin sheath, and the diameter of the axons
were almost the same as in the normal group. In conclusion, EPO supplementation may be beneficial as a therapeutic option for
disturbances of nerve interaction.
1. Introduction
Peripheral nerve encompasses all the nerve trunks and
branches which lie outside the central nervous system.When
a peripheral nerve is injured, the muscles supplied by that
nerve do not receivemessages from the brain.Therefore, they
becomeweakened or paralysed [1, 2]. Traffic collisions usually
induce traumatic nerve injuries resulting from disruption
of the intraneural circulation [3, 4]. This condition con-
sequently induces demyelinization, remyelinization, axonal
degeneration and axonal regeneration, focal, multifocal, or
diffuse nerve fibre loss, and endoneural edema [4, 5]. Nerve
regeneration is a complex phenomenon that has been gaining
interest among scientists for many years. Many experimental
studies have focused on treatment options to enhance the
recovery process of injured peripheral nerves in the rat
model. This includes the application of an electric field
[6], extracts of various natural products, for example, the
medicinal mushroom Hericium erinaceus [7], and surgical
intervention, for example, nerve grafts and transplanting
stem cells [8]. Many experimental studies have focused on
treatment options to enhance the recovery process of injured
peripheral nerves in the rat model. This includes the applica-
tion of an electric field [6], surgical intervention, for example,
nerve grafts and transplanting stem cells [8]. Furthermore,
the transplantation of Schwann cells has also been shown to
improve functional recovery and reduce histological deficits
resulting from nerve crush injury [9]. Despite being the
major producer of myelin in the peripheral nervous system,
Schwann cells play an important role in promoting axonal
regeneration by producing neurotrophic factors such as nerve
growth factor (NGF) and ciliary neurotrophic factor (CNTF)
[10]. Commercial drugs such as immunosuppressant and
anti-inflammatory drugs may accelerate the rate of nerve
regeneration following injury. However, they are associated
with severe side effects such as high blood pressure, kidney
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problems, and liver disorders [11]. Therefore, it is important
to search for natural products or substances and possible new
drug treatments that could help improve nerve regeneration.
Evening primrose is a biennial herb originating from
North America. Its botanical name is Onoethera biennis.The
seeds of this herb are very valuable as they contain beneficial
oil, evening primrose oil. The potential benefits of evening
primrose oil, or EPO, are derived from the active ingredient
called gamma-linolenic acid (GLA) (the major commercial
source of GLA), which is an essential fatty acid. GLA is
necessary for human health and may also be obtained from
vegetable oils such as safflower oil (Carthamus tinctorius),
blackcurrant seed oil, and borage oil. EPO is one of the
safest sources of GLA [12, 13]. EPO contains 8%–11% GLA
and about 70% Linoleic acid such as Eicosanoid Acid (EA)
and palmitic, stearic, and oleic acid [14]. Evening primrose
is known as King’s Cure-all [15]. This could possibly be
due to its role in treating many diseases including atopic
dermatitis, rheumatoid arthritis, mastalgia, and breast cysts
[16]. In addition, EPO is also effective in controlling high
blood pressure, assisting circulation, andmaintaining healthy
arteries, thereby preventing heart disease [17]. EPO has
phytoestrogenic effects and is widely used as a complemen-
tary treatment in combating premenstrual tension and also
as a postmenopausal treatment [18]. Certain studies have
reported that consumption of EPOhas been shown to prevent
and rapidly reverse the nerve conduction velocity (NCV)
of deficits found in the rat nerve. Diabetic animals and
humans have a reduced ability to convert dietary linoleic acid
into GLA. GLA and its metabolites are required for normal
neuronal structure, function, and a normal microcirculation.
A lack of GLA and its metabolites may play a major role in
the development of neuropathy [19].
A study carried out where patients were given 360mg
GLA a day for a period of 6 months demonstrated that
the patients who took GLA showed statistically significant
improvement in neuropathy symptom scores after this time
period [20]. The conclusion of the study was that GLA
therapy might have a useful role in the prevention and
treatment of distal diabetic polyneuropathy. Another study
was conducted among patients taking 480mg GLA a day
for a one-year period concluded that GLA had a beneficial
effect on the course of diabetic neuropathy [21]. In addition
other studies have shown that motor and sensory conduction
deficits were largely corrected in an EPO-treated reversal
group, with the degree of amelioration compared to one-
month diabetic control being 99% (𝑝 < 0.001) and 85%
(𝑝 < 0.01), respectively [21]. Other researches have been
done concerning peripheral nerve degeneration, as well as
treatment and regeneration, from experimental studies in
small animals, especially rats. This is because the speed of
regeneration in these animals is fairly fast [22]. Sciatic nerve
crush injuries are an ideal method of studying nerve injuries
and regeneration. This is especially so when a therapeutic
approach is under investigation, as it does not involve
complete damage to the side of the nerve, for example, the
epineurium, as is the case with section and repair [22]. The
present study was conducted to observe the morphological
changes tomyelin and axons in rat sciatic nerve crush injuries
using Toluidine Blue staining. The aim of this study is to
determine the effect of EPO supplementation on the rate
of peripheral nerve regeneration after sciatic nerve injury,
through morphological and morphometric analysis of the
injured nerve.
2. Materials and Methods
2.1. Animals and Surgical Procedures. In the present study, 72
healthy adult Sprague-Dawley rats that were about 8 weeks
old (weighing 250 ± 50 g) were obtained from the animal
house, Faculty of Medicine, University of Malaya. The care
and procedures for animal experiments conformed to the
guidelines of the Animal Care and Use Committee (ACUC)
[Vot number ANA 14/07/2010/JS (R)], University of Malaya.
The rats were classified into three groups.
Group 1. Normal group (𝑛 = 8): the rats did not undergo
sciatic nerve crush injury and served as control for the
histological study. The rats were fed with a conventional diet
ad libitum.
Group 2. Control group (𝑛 = 32): the rats underwent sciatic
nerve crush injury and were not supplemented with EPO.
The rats were divided into four groups (1, 2, 3, and 4 weeks).
Each group consisted of 8 rats. The rats were fed with a
conventional diet ad libitum.
Group 3. Experimental group (𝑛 = 32): sciatic nerve crush
injury was performed and the rats were supplemented with
6000mg/day EPO. The rats were divided into four groups
(1, 2, 3, and 4 weeks). Each group consisted of 8 rats. The
rats were fed with a conventional diet ad libitum. The rats
were anesthetized with a mixture of ketamine (100mg/kg)
and xylazine (10mg/kg). The nerve crush procedure was
performed on the right hind limb whereas the left side served
as control. The site of the incision was shaved and the skin
incised over a length of 2 cm along the proximal half of the
line between the trochanter major and the knee joint. The
right sciatic nerve was exposed through a gluteal muscle
splitting incision, through which the overlying lateralis and
biceps femoris muscles were separated without cutting the
muscle fibres, using a pair of Watchmaker’s forceps.
The visible sciatic nerve was crushed 1 cm proximal to
the division of the sciatic nerve into the tibial and common
peroneal nerves. The crush was achieved by applying 15
seconds of consistent pressure with a pair of sterile modified
Watchmaker’s forceps. A spacer was used at closure point to
achieve moderate injury. The nerve was checked to ascertain
that the epineurium was intact and that the nerve was
completely crushed. This was done by raising the nerve
slightly using a microprobe so that a clear area in the nerve
was observed, which indicated a complete nerve crush. The
skin incision was sutured and the rat was placed on a heating
pad to keep it warm. Each rat received 1ml of Lactated
Ringer’s solution subcutaneously and 0.4mg/kg of Baytril
intramuscularly. 10mg/g of Chloramphenicol and 5mg/g of
HydrocortisoneAcetate ointmentwere applied to the incision
area. The rats were monitored until they recovered from the
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Table 1: The scoring and grading of the toe-spreading reflex.
Toe-spreading reflex (Gutmann 1942)
Grade Clinical symptoms
Degree 0 Absence of any abduction (movement) in any digit.
Degree I Just visible spreading of the 4th toe alone (or one of the digit)
Degree II Slight spreading of all three toes
Degree III Spreading of all three toes less forceful than normal
Degree IV Full spreading of all three toes (which resembles the unoperated left site)
The toe-spreading reflex is an excellent and sensitive indicator of the onset of nerve and motor neuron recovery [24].
anesthesia. After this, the rats were placed in their respective
cages. Each rat was observed postoperatively to confirm
complete crushing of the nerve shown by paralysis of the
muscles to the toes and no spreading of the toes. Rats with
movement in the toes, indicating incomplete nerve crush,
were rejected from the group.
2.2. Histological and Morphometric Studies. The rats were
sacrificed at different time points (7, 14, 21, and 28 days after
operation). The point of the nerve crush was determined
(1 cm before the bifurcation of the sciatic nerve) and the
nerve was harvested for histological preparation. The sciatic
nerve was dissected out and fixed in 4% Glutaraldehyde in
Millonig’s Phosphate Buffer for 24–72 hours, prior to the
embedding process. The embedded sciatic nerve was serially
cross-sectioned at a thickness of 50 𝜇m using a microtome.
The sections of the sciatic nerve were stained with Toluidine
Blue solution to quantitatively evaluate the regeneration of
the sciatic nerve. The stained slides were mounted using
DPX and observed under a light microscope equipped with
a camera linked to a computer loaded with NIS-Element
software to visualize the axons andmyelinmorphology of the
sciatic nerve.
2.3. Dietary Supplementation. After the nerve crush proce-
dure, the rats were fed according to the diet assigned for
their groups for 4 weeks, during which behavioural testing
was performed daily. All group were fed with standard rat
chow. In addition, the experimental group were given EPO
6000mg/day through an esophageal feeding tube starting
from day 1 after nerve crush. The EPO administration is
considered safe as no toxicity, carcinogenicity, or teratogenic-
ity has been reported with high oral administration of EPO
during clinical trial [23]. In addition, a higher dose was
selected to determine if a higher dose than that used in
Samsinah et al. (1999) would be better for nerve regeneration.
2.4. Functional Assessment. After surgery, the rats were
inspected every single day. During these inspections, each
rat was held by its tail above a surface and then lowered
down onto it and carefully observed for a minute or two
[23]. Activities were classified according to the toe-spreading
reflex of the affected right hind limb: no spreading, minimal
spreading, average spreading, and normal spreading. The
toe-spreading reflex was elicited to measure the duration of
complete recovery of the nerve. The behavioural observation
was based on comparison of the reflex seen between the right
side of the leg (where the nerve crush was performed) and
the left side of the leg (which served as control). The first
reading was at day 0 (after nerve crush injury) as shown in
Table 1. The reflex was checked for 4 weeks. The scoring of
the toe-spreading reflexwas based on a 5-point scale as shown
in Table 1.
2.5. Statistical Analysis. All the data were analyzed and
compared between each group. Statistical significance was
determined using one-way analysis of variance (ANOVA)
and post hoc analysis (SPSS Version 20). Significant changes
were determined using Tukey’s test formultiple comparisons.
Differences were considered to be significant at 𝑝 < 0.05.
The normality of all data distributions was checked using the
Kolmogorov-Smirnov test.
3. Results
3.1. Histological Analysis of Myelin and Axon. The light
microscopic sections of sciatic nerve stained with Toluidine
Blue at various time points are shown in Figure 1, where
Figure 1(a) represents a photomicrograph of a normal rat. It
shows the normal distribution of axon size, number, and also
myelin thickness. Few macrophages are visible in the normal
group. From the histological study, it was clear that the axons
in the normal group were consistently round in shape with a
thick myelin sheath. The axons consisted of both myelinated
and unmyelinated axons. A myelinated axon has a sheath of
myelin layer around it while an unmyelinated axon does not.
Besides that, the axon and myelin population was notably
high. The axon/fibre diameter was also notably high.
When compared to the normal group, the control group
depicts irregular axon shape with a thinner myelin sheath.
The number of axon andmyelin was lower than in the normal
group. In this group, the diameter of axons was notably
smaller than the normal and experimental group. At Day 7
after operation, as seen in Figure 1(b), there was a diffuse
loss of large myelinated axons and both the axon number and
myelin thickness had decreased tremendously. Macrophages
(arrow in the figure) were visible and their number was
greater. Starting from Day 14 up to Day 28 after injury,
both axon number and myelin thickness increased with
time.
In the experimental group, axonal sprouting was noted
with a population of smaller axons as early as Day 7 after
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Figure 1:These photographs illustrated sections of sciatic nerve stained with Toluidine Blue at various time points. (a) Normal rat. (b) 7 days
after operation. (c) 14 days after operation. (d) 21 days after operation. (e) 28 days after operation. Scale bar = 50𝜇m (arrow: macrophages,
where the thick arrow indicates macrophage engulfing degenerating myelin sheath).
operation (Figure 2(a)). Evidence of regeneration was noted
by the appearance of a large number of macrophages popula-
tions (early nerve crush injury) which were swollen with the
phagocytosis of degenerative debris, which strongly indicated
that the nerve was still in the process of degeneration, while
at Day 14 and Day 21 after operation, the population and size
of the axon and myelin were increased over time (Figures
2(b) and 2(c)). In the experimental group, on Day 28 after
operation (Figure 2(d)), the shape and diameter of the axons
and also the thickness of the myelin sheath were similar to
that of the normal group. The rats in the control group were
still undergoing the regeneration process with the appearance
of macrophages, when the rats in the experimental group had
achieved complete recovery. However, in the control group,
the axons were very small and there was no myelin sheath
in nearly all of the axons in the nerve (refer to Figures 1(b),
1(c), and 1(d)).This indicates that the process ofmyelin sheath
restoration was slow in the control group, as the experimental
group had achieved complete recovery by the same time
point.
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(c) (d)
Figure 2:These photographs illustrated sections of sciatic nerve stained with Toluidine Blue at various time points. (a) 7 days after operation.
(b) 14 days after operation. (c) 21 days after operation. (d) 28 days after operation (treated with EPO) (arrow: macrophages).
Table 2: Pairwise comparisons of the toe-spreading reflex. Measure: MEASURE_1.
(I) group (J) group Meandifference (I − J)
Std.
error Sig.
b 95% confidence interval for differenceb
Lower bound Upper bound
Normal Control 1.900
∗ .031 .000 1.820 1.980
EPO .400∗ .031 .000 .320 .480
Control Normal −1.900
∗ .031 .000 −1.980 −1.820
EPO −1.500∗ .031 .000 −1.580 −1.420
EPO Normal −.400
∗ .031 .000 −.480 −.320
Control 1.500∗ .031 .000 1.420 1.580
Based on estimated marginal means. ∗Themean difference is significant at the .05 level. bAdjustment for multiple comparisons: Bonferroni.
3.2. Behavioural Analysis. The pairwise comparison tables
and line graph of the mean score difference of toe-spreading
reflex scores plotted for the normal, control, and experimen-
tal group are shown in Table 2 and Figure 3. The pairwise
comparison reflects that there was significant difference in
toe-spreading reflex between the normal and the control
groups (1.9 ± 0.031, 𝑝 < 0.05) and the normal and the EPO
groups (0.4 ± 0.031, 𝑝 < 0.05) and significant difference
between EPO and the control groups (1.5 ± 0.031, 𝑝 <
0.05) as shown in Table 2. The mean difference between
the normal and EPO is evidently low, suggesting better TSR
recovery rate. From the graph, a score of 4 (blue line) indicates
the toe-spreading reflex of a normal uninjured hind limb
while a score of 0 indicates an absence of reflex in any of
the digits of the hind limb due to the immediate effect of
sciatic nerve crush injury. Seven days after operation, the toe-
spreading reflex in the control group (red line) was compared
with the same reflex in the EPO-treated group (green line),
the difference in the scores between these two groups was
statistically significant (𝑝 < 0.05, two-tailed unpaired 𝑡-
Test). In the control group, all rats showed some improvement
(recovery process) in the toe-spreading reflex score 7 days
after operation, but compared to the EPO-treated group it
showed faster recovery as early as day 1 after operation. For
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Figure 3: Graph of mean toe-spreading reflex score versus time.
the EPO-treated group, all the rats showed toe-spreading
reflex score of 4 before surgery as they were in normal
condition. After the sciatic nerve crush injury, the toe-
spreading reflex score of the rats in control and experimental
groups dropped as they lose their function. But, a week after
nerve crush injury, the increased toe-spreading reflex score
indicated that the rats have improved their function. The
efficacy of EPO was seen when the toe-spreading reflex score
for the experimental group was higher compared to those
in the control group and the differences were significant;
difference was seen at day 7 and 14 and 21 days after operation
(𝑝 < 0.05, two-tailed unpaired 𝑡-Test).
3.3. Morphometric Evaluation Myelin and Axon. The graph
of the mean axon area of the sciatic nerve in the rats of
the normal, control, and experimental groups is shown in
Figure 4. From the data observed, after the nerve crush injury,
the size of the axon area was significantly reduced (refer to
control group at day 7 after operation, Figure 4) compared
to the normal group, but after that the size of the axon area
increased gradually over time. In the control group, it was
found that at day 7 after operation there was a significantly
higher percentage loss of the axon area (19.6%) compared
to the experimental group, where it was only 15.3%. This
shows that the EPO supplementation decreased axon area
loss by 4.3%. In the control group at day 14 after operation
it was found that there was a 16.8% loss of the axon area
compared to the experimental group which was about 13.4%.
At 21 days after operation 16% loss of the axon area was found
compared to the experimental group which lost about 10.6%.
While, in the control group, it was found that at day 28 after
operation there was 14% loss of the axon area compared to the
experimental group, where it was only 9.6% loss of axon area.
Thus, this data indicates that EPO supplementation may
be related to successful regeneration growth following sciatic
nerve crush injury in the rat.
Axon area
Error bars: 95% CI
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Figure 4: Mean axon area. The graph shows the value of the Mean
Axon Area (𝜇m2) of the sciatic nerve with standard deviations
(vertical bars). ∗𝑝 < 0.05, one-way ANOVA when compared at the
same time point between control and experimental groups. #𝑝 < 0.05,
one-way ANOVA when normal group compared with control and
experimental groups at each time point.
The mean axon diameter of the sciatic nerve in rats of
the normal, control, and experimental groups is shown in
Figure 5. From the data observed, after the nerve crush injury,
the size of the axon diameter was completely reduced (refer to
control group day 7 after operation) compared to the normal
group but after that the size of the axon diameter increased
gradually over time. In the control group, it was found that,
at day 7 after operation, there was a significantly bigger
percentage reduction of the axon diameter (23%) compared
to the experimental group where it was only 13.7%. In the
control group at days 14 and 21 after operation 14.8% and
10.7% loss of the axon diameter, respectively, were found
compared to the experimental group which was about 8.6%
and 4.1%, respectively, while, in the control group, it was
found that at day 28 after operation there was 5.15% loss
of the axon diameter compared to the experimental group,
where it was only 1.03% loss of the axon diameter. Thus, this
data indicates that EPO supplementation may be related to
successful regeneration growth following sciatic nerve crush
injury in the rat.
Figure 6 shows the mean myelinated axon number which
was 7116 for the control group, while for the rats at 7, 14, 21,
and 28 days after operation it was 5535, 6281, 6624, and 6620,
respectively, with significant differences between the control
group and each of the experimental groups. This shows that,
28 days after the injury, the mean myelinated axon number
was still significantly reduced/little compared to that of the
control rats. There was a significant (𝑝 < 0.05) 22.2% loss of
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Figure 5: Mean axon diameter. The graph shows the value of
the Mean Axon Diameter (𝜇m) of the sciatic nerve with standard
deviations (vertical bars). ∗𝑝 < 0.05, one-way ANOVA when
compared at the same time point between control and experimental
groups. #𝑝 < 0.05, one-way ANOVA when normal group is
compared with control and experimental groups at each time point.
myelinated axons at day 7 after operation in the control group
compared to the experimental group where it was only 10.4%
at the same time point.
In the control group at days 14 and 21 after operation 11.7%
and 6.91% loss of the myelinated axon number were found,
respectively, compared to the experimental group which was
about 5.8% and 3.5%, respectively, while, in the control group,
it was found that at day 28 after operation there was 7% loss of
the myelinated axons number compared to the experimental
group, where it was only 1.2% loss of the myelinated axons
number.
All the data show significant differences (𝑝 < 0.05)
between the control group and experimental group at days
7, 14, and 28 after operation but no significant difference
was found between the control and experimental group at
day 21 after operation. Thus, this data indicates that EPO
supplementation may be related to successful regeneration
growth following sciatic nerve crush injury in the rat.
Figure 7 shows the mean myelinated fibre area of the
sciatic nerve in rats of the normal, control, and experimental
groups. From the data observed, after the nerve crush injury,
the mean myelinated fibre area was completely reduced
(refer to control group day 7 after operation) compared
to the normal group but after that it increased gradually
over time. In the control group, it was found that at day 7
after operation there was a significantly higher percentage
loss of the myelinated fibre area (33%) compared to the
Myelinated axon number
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Figure 6: Mean myelinated axon number. The graph shows the
value of the mean myelinated axon number of the sciatic nerve
with standard deviations (vertical bars). ∗𝑝 < 0.05, one-way
ANOVA when compared at the same time point between control and
experimental groups. #𝑝 < 0.05, one-way ANOVA when normal
group is compared with control and experimental groups at each time
point.
experimental group where it was only 29%. In the control
groups at days 14 and 21 after operation 30.9% and 29.1%
loss of the myelinated fibre area were found, respectively,
compared to the experimental group which was about 27.1%
and 20.1%, respectively, while, in the control group, it was
found that at day 28 after operation there was 27.5% loss of the
myelinated fibre area compared to the experimental group,
where it was only 14.8% loss of the myelinated fibre area. All
the data show significant differences (𝑝 < 0.05) between
the control group and experimental group at days 7, 14, 21,
and 28 after operation. Thus, this data indicates that EPO
supplementation may be related to successful regeneration
growth following sciatic nerve crush injury in the rat.
Figure 8 shows the mean myelin area of the sciatic nerve
in the rats of normal, control, and experimental groups. From
the data observed, after the nerve crush injury the size of the
myelin area was completely reduced (refer to control group
day 7 after operative) compared to the normal group but
after that the size of the myelin area increased gradually over
time. In the control group, it was found that, at day 7 after
operation, there was a significantly higher percentage loss
of myelin area (29.5%) compared to the experimental group,
where it was only 24.6%. In the control group at days 14 and 21
after operation 25.7% and 23.4% loss of the myelin area were
found, respectively, compared to the experimental group
which was about 22.9% and 18.7%, respectively, while, in the
control group, it was found that at day 28 after operation
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Figure 7: Mean myelinated fibre area. The graph shows the value of
the mean myelinated fibre area of the sciatic nerve with standard
deviations (vertical bars). ∗𝑝 < 0.05, one-way ANOVA when
compared at the same time point between control and experimental
groups. #𝑝 < 0.05, one-way ANOVA when normal group is compared
with control and experimental groups at each time point.
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Figure 8: Mean myelin area. The graph shows the value of the
meanmyelin area (𝜇m2) of the sciatic nervewith standard deviations
(vertical bars). ∗𝑝 < 0.05, one-way ANOVA when compared at the
same time point between control and experimental groups. #𝑝 < 0.05,
one-way ANOVA when normal group compared with control and
experimental groups at each time point.
there was 20.2% loss of the myelin area compared to the
experimental group,where it was only 11.6% loss of themyelin
area.Thus, this data indicates that EPO supplementationmay
be related to successful regeneration growth following sciatic
nerve crush injury in the rat.
4. Discussion
The results of this study indicate that supplementation with
EPO is effective for sciatic nerve crush injury in a variety of
rodentmodels especially the ratmodel.The present studywas
conducted to determine the potential effect of EPO supple-
mentation on the rate of peripheral nerve regeneration after
sciatic nerve injury, through morphological and morpho-
metric analysis of the injured nerve. Oral supplementation
of EPO was capable of enhancing nerve regeneration and
speeding up the functional recovery of the nerve after the
nerve crush injury in the rat.
Based on both the behavioural and histological outcomes,
themost significant finding in this study is that EPOpossesses
potential benefits in improving the toe-spreading reflex
(behavioural test) and reducing morphological damage to
the sciatic nerve. Many techniques have been developed by
researchers and scientists around the world to induce crushes
to the sciatic nerve. The most commonly used model is
the contusion model. This induces a sciatic nerve injury by
weight drop and impactor rod [25]. In this study, we used
modified Watchmaker’s forceps to induce a crush injury to
the sciatic nerve as it is easy to use, is affordable, and has
proven to be clinically relevant. Using forceps with different
separation distances (calibrated ignition gauge or spacers)
at closure point, it is possible to achieve mild, moderate,
and severe injuries that can be distinguished histologically or
otherwise [26]. However, the forceps induced compression
cannot compute the velocity or force delivered at the injury
site but it has been shown to be widely used and allows
control of injury induction [26]. Our results are similar to the
findings of other researchers who have also used forceps to
induce crushes in sciatic nerve models [26]. The functional
recovery assessment that was used in the present study was
the toe-spreading reflex. A simple, precise, and inherently
meaningful measure is the return of toe-spreading [27]. In
the present study, the findings of functional recovery are
supported by histological analysis of the myelin and axon
morphology and morphometric analysis. It was found that
complete nerve recovery was noted as early as day 9 and as
alate as day 15 in experimental group. The mean of complete
nerve recovery was at day 12. EPO treatment, therefore,
reduced the time taken for complete nerve recovery by 14 days
compared to the control group. Furthermore, the result shows
that the mean difference between the normal and the EPO
group is evidently low compared to the high mean difference
between the normal and control group. The implication is
that EPO leads to statistically significant TSR recovery at the
end experiment (𝑝 < 0.05). This reduction of 53.8% is higher
than the 34.8% reduction observed in the past study [28]
where the reduction is statistically significant (𝑝 < 0.005).
Morphologic and morphometric analysis were used to
evaluate the condition of the sciatic nerve after nerve crush
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injury, and the results were compared to those obtained with
the same animals with respect to functional assessment (toe-
spreading reflex). In the present study, it should be noted
that (in the histological studies) the epineurium was never
disrupted in any of the groups, but the perineurium and
endoneurium were affected. The histological analysis clearly
showed that the myelin was well-arranged in the rats from
the normal group but was scattered and irregularly shaped
in the rats from the control group. The micrographs of the
semithin Toluidine Blue staining showed that the axons and
myelin in the experimental group (28 days after operation)
had completely recovered or were not markedly different
from those of the normal group. At 28 days after operation
(experimental group), the axons displayed a rounded struc-
ture and the appearance of the myelin sheath became thicker
compared to earlier in the nerve crush injury (7 days after
operation).The observed myelin sheath changes were similar
to previous studies as evaluation studies as this parameter
allows for discrimination of the pathological condition of a
peripheral nerve from a morphologically and physiologically
intact nerve [29–31]. At 7 days after operation, the axons
displayed a population of regenerating axons. The size of the
axons was small and the myelin sheath was not visible.
From the histological analysis, the mean axon area had
significantly decreased from 8.95 𝜇m2 in the normal group
to 7.20𝜇m2 7 days after the crush injury (control group).
After that, it demonstrated a relative increase 7 days after
operation up to 28 days after operation. This finding was
comparable with that of a previous study [22] where the
value of the normal mean axon area was in the range of
5.38–9.41 𝜇m2. Meanwhile, the mean axon diameter followed
the same trend as the diameter of the normal axon pro-
gressively and significantly decreasing from 2.91𝜇m (normal
group) to 2.24𝜇m 7 days after the crush injury (control
group). This is similar to or not markedly different from
the results displayed in previous studies, which indicated
that the diameter of the normal axon was in the range
of 3.0–3.5 𝜇m and 2.17–2.96𝜇m [29]. Based on our study,
the normal mean myelin area was 10.10 𝜇m2. It significantly
decreased to 7.12 𝜇m2 7 days after the crush injury. This
finding is supported by the results of previous studies [32]
where the value of the normal mean myelin area was 12.75 ±
4.37 𝜇m2. Similar behaviour was observed for all of the other
morphometric parameters (namely, the myelinated fibre area
and myelinated axon number), which significantly decreased
in all crush injury groups (control and experimental groups)
compared to the normal group. However, since most of the
differences between the crush injury groups were significant,
these findings may be considered normal and indicate that
the nerve crush injury produced consistent and virtually
similar results [22]. It has been reported that EPO supple-
mentation was responsible for accelerated axonal regrowth
in sciatic nerve injured rats [28, 33]. We also believed that
EPO can improve Schwann cell proliferation. Schwann cells
are responsible for the myelination of peripheral axons. This
process occurs when Schwann cell wrap around the axons,
creating a myelin sheath from multiple concentric layers of
cytoplasmic membrane [4]. The EPO acts via GLA which is
a substrate for production of vasodilator prostanoids such as
prostacyclin to improve nerve perfusion [34]. Further studies
also suggests that cyclooxygenase mediated metabolites such
as prostacyclin are vital for EPO’s actions and are necessary
for maintaining the integrity of sciatic vasa nervorum in rats
[35].
5. Conclusion
In conclusion, the injury model that has been used in this
investigation is an efficient, cost-effective, and ideal way to
induce sciatic nerve crush injury in rats. Based on the findings
obtained in this study, daily oral EPO supplementation has
been shown to enhance the recovery of damaged peripheral
nerve. A dose of 6000mg/day of EPO supplementation helps
accelerate nerve regeneration and, therefore, might have a
vital role in the therapy of peripheral nerve injury.
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